 | | | | Google will clearly label medical facilities in the United States that provide abortions in its search results and in Google Maps to avoid confusing them with anti-abortion centers, its top executive informed lawmakers on Thursday. | | | | | | New abortion bans are taking effect in five U.S. states this week, adding to the raft of restrictions states have enforced since the U.S. Supreme Court ended the nationwide right to abortion in June. | | | | | | The number of monkeypox cases reported globally declined by 21% last week, after a month-long trend of rising infections, the World Health Organization said on Thursday. | | | | | | Chinese customs said on Thursday it no longer required cross-border travellers to report certain COVID-related information, such as tests and previous infections, when clearing customs. | | | | | | Pfizer Inc said on Thursday its vaccine for Respiratory Syncytial Virus (RSV) was effective among older adults in a late-stage study and it plans to file for approval with the U.S. health regulator in the coming months. | | | | | | The United States plans to roll out an updated COVID-19 booster vaccine to include Omicron subvariants of the coronavirus. Regulators are reviewing the shots and could give the go-ahead as soon as next week. | | | | | | Thai drugmaker Siam Bioscience, owned by the country's king, reported a near 50-fold increase in annual profit in 2021, when it began producing AstraZeneca Plc's COVID-19 vaccine, government data shows. | | | | | | North Korea's state media said on Thursday that a fever outbreak of unknown origin has emerged in a region bordering China, but it was not the novel coronavirus over which the country declared victory this month. | | | | | | The U.S. Centers for Disease Control and Prevention (CDC) on Monday signed off on the use of Novavax Inc's COVID-19 vaccine for adolescents aged 12 through 17. | | | | | | AstraZeneca may not stay in the vaccine business in the long run, its CEO told Reuters on Tuesday, showing how quickly fortunes have changed for the drugmaker that produced one of the first COVID-19 shots but has since lost out to rivals. | | | | | |
